UBS Group’s Strategic Trust Kelly CRISPR & Gene Editing Technology ETF XDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-419
| Closed | -$3.11K | – | 9029 |
|
|
2023
Q3 | $3.11K | Buy |
+419
| New | +$3.11K | ﹤0.01% | 6465 |
|
|
2023
Q1 | – | Sell |
-5,352
| Closed | -$53.2K | – | 9560 |
|
|
2022
Q4 | $53.2K | Sell |
5,352
-166
| -3% | -$1.65K | ﹤0.01% | 5568 |
|
|
2022
Q3 | $65K | Buy |
5,518
+5,367
| +3,554% | +$63.2K | ﹤0.01% | 5035 |
|
|
2022
Q2 | $2K | Buy |
+151
| New | +$2K | ﹤0.01% | 8641 |
|